Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Extended Data Table 1 Summary of all TRAEs occurring in ≥ 5% of patients among (A) all monotherapy patients and (B) patients with SCLC in the 1.8 mg kg−1 and 2.5 mg kg−1 part 2 dose-optimization cohorts
